Hiland Dairy is announcing a voluntary recall of two products produced at the Omaha, Nebraska facility, over concerns the products may contain milk protein that could affect those individuals that have sensitivity to milk allergens. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products. No illnesses or allergic reactions have been reported at this time.
All posts by admin
Rico Brand Issues Allergy Alert on Undeclared Soy in Tofu Breakfast Burrito
Rico Brand of Salt Lake City, Utah is recalling Tofu Breakfast Burrito, because it may contain undeclared Soy. People who have an allergy or severe sensitivity to Soy run the risk of serious or life-threatening allergic reaction if they consume these products.
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA decision to seek additional time to reassess rule that would have changed longstanding practices for how the agency determined the ‛intended use’ of medical products
: FDA decision to seek additional time to reassess rule that would have changed longstanding practices for how the agency determined the ‛intended use’ of medical products
FDA approves first treatment for breast cancer with a certain inherited genetic mutation
FDA approves first treatment for breast cancer with a certain inherited genetic mutation
Fieldbrook Foods Corporation Clarifies Scope of its Voluntary Recall. Products Include Orange Cream
Fieldbrook Foods Corporation is clarifying that the previously announced voluntary recall of all orange cream bars
and chocolate coated vanilla ice cream bars that were produced in 2017 on the company’s Hoyer 1 Line at its
Dunkirk, NY plant (plant code 362677) also includes 28,751 cases of Raspberry Cream Bars that were included
with Orange Cream Bars in ALDI seasonal split-case purchases.
Hom/Ade Foods, Inc. Voluntarily Recalls Frozen Biscuits Because of Possible Health Risk
Hom/Ade Foods, Inc is voluntarily recalling Mary B’s® brand biscuits due to potential contamination with Listeria monocytogenes. The problem was discovered in a product sampling conducted by an outside co-packer, who manufactured the product.
Pharmedium Services, LLC Expands Voluntary Nationwide Recall of Additional Lots of Compounded Sterile Products Within Expiry Due to Lack of Sterility Assurance
January 10, 2018 Lake Forest, IL PharMEDium Services, LLC (PharMEDium) is voluntarily expanding the recall issued on December 27, 2017 to include the below lots of sterile drug products to the hospital/user level due to a lack of assurance of sterility. Administration of a drug product intended to be sterile that is not sterile could result in serious infections that may be life-threatening.
Gilster – Mary Lee Corp. Issues a Recall For Undeclared Milk Allergen in Essential Everyday® Chicken Coating
January 8, 2018 – Gilster-Mary Lee, 520 Old St. Mary’s Road, of Perryville, Missouri, is voluntarily recalling one lot of Essential Everyday® Coat & Bake Original Chicken coating, UPC 41303-01572 at the consumer level because it may contain undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products.
FDA warns Becton Dickinson & Company of significant violations of the law as part of ongoing investigation into lead testing issues
FDA warns Becton Dickinson & Company of significant violations of the law as part of ongoing investigation into lead testing issues
FDA acts to protect kids from serious risks of opioid ingredients contained in some prescription cough and cold products by revising labeling to limit pediatric use
The U.S. Food and Drug Administration announced today that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years old because the serious risks of these medicines outweigh their potential benefits in this population. After safety labeling changes are made, these products will no longer be indicated for use to treat cough in any pediatric population and will be labeled for use only in adults aged 18 years and older. Labeling for the medications also is being updated with additional safety information for adult use – including an expanded Boxed Warning, the FDA’s most prominent warning ‒ notifying about the risks of misuse, abuse, addiction, overdose and death, and slowed or difficult breathing that can result from exposure to codeine or hydrocodone.